YAP1 Expression in SCLC Defines a Distinct Subtype With T-cell–Inflamed Phenotype
Taofeek K. Owonikoko(UPMC Hillman Cancer Center), Gabriel Sica(Emory University), Guojing Zhang(Emory University), Shi‐Yong Sun(Emory University), Sagar Lonial(Emory University), Walter J. Curran(Piedmont Cancer Institute), Vinicius Ernani(Emory University), Bhakti Dwivedi(Emory University), Zhengjia Chen(Hunan University of Traditional Chinese Medicine), Melissa Gilbert‐Ross(Emory Healthcare), Andrei A. Ivanov, Fadlo R. Khuri(American University of Beirut Medical Center), Benjamin G. Barwick(Emory University), Haian Fu(Emory University), Suresh S. Ramalingam(Emory University), Edmund K. Waller(Emory University), Chao Zhang(Emory University), Jennifer W. Carlisle(Emory University)
Cited by 166
Related Papers
Osimertinib or Platinum–Pemetrexed in <i>EGFR</i> T790M–Positive Lung Cancer
|New England Journal of Medicine|2016|3.3k
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
|The Lancet|2004|2.4k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Sotorasib for Lung Cancers with <i>KRAS</i> p.G12C Mutation
|New England Journal of Medicine|2021|1.8k